"use strict";(self.webpackChunkaurorahelp=self.webpackChunkaurorahelp||[]).push([[4546],{3905:(e,t,a)=>{a.d(t,{Zo:()=>h,kt:()=>p});var i=a(7294);function n(e,t,a){return t in e?Object.defineProperty(e,t,{value:a,enumerable:!0,configurable:!0,writable:!0}):e[t]=a,e}function r(e,t){var a=Object.keys(e);if(Object.getOwnPropertySymbols){var i=Object.getOwnPropertySymbols(e);t&&(i=i.filter((function(t){return Object.getOwnPropertyDescriptor(e,t).enumerable}))),a.push.apply(a,i)}return a}function o(e){for(var t=1;t<arguments.length;t++){var a=null!=arguments[t]?arguments[t]:{};t%2?r(Object(a),!0).forEach((function(t){n(e,t,a[t])})):Object.getOwnPropertyDescriptors?Object.defineProperties(e,Object.getOwnPropertyDescriptors(a)):r(Object(a)).forEach((function(t){Object.defineProperty(e,t,Object.getOwnPropertyDescriptor(a,t))}))}return e}function l(e,t){if(null==e)return{};var a,i,n=function(e,t){if(null==e)return{};var a,i,n={},r=Object.keys(e);for(i=0;i<r.length;i++)a=r[i],t.indexOf(a)>=0||(n[a]=e[a]);return n}(e,t);if(Object.getOwnPropertySymbols){var r=Object.getOwnPropertySymbols(e);for(i=0;i<r.length;i++)a=r[i],t.indexOf(a)>=0||Object.prototype.propertyIsEnumerable.call(e,a)&&(n[a]=e[a])}return n}var s=i.createContext({}),c=function(e){var t=i.useContext(s),a=t;return e&&(a="function"==typeof e?e(t):o(o({},t),e)),a},h=function(e){var t=c(e.components);return i.createElement(s.Provider,{value:t},e.children)},u="mdxType",d={inlineCode:"code",wrapper:function(e){var t=e.children;return i.createElement(i.Fragment,{},t)}},m=i.forwardRef((function(e,t){var a=e.components,n=e.mdxType,r=e.originalType,s=e.parentName,h=l(e,["components","mdxType","originalType","parentName"]),u=c(a),m=n,p=u["".concat(s,".").concat(m)]||u[m]||d[m]||r;return a?i.createElement(p,o(o({ref:t},h),{},{components:a})):i.createElement(p,o({ref:t},h))}));function p(e,t){var a=arguments,n=t&&t.mdxType;if("string"==typeof e||n){var r=a.length,o=new Array(r);o[0]=m;var l={};for(var s in t)hasOwnProperty.call(t,s)&&(l[s]=t[s]);l.originalType=e,l[u]="string"==typeof e?e:n,o[1]=l;for(var c=2;c<r;c++)o[c]=a[c];return i.createElement.apply(null,o)}return i.createElement.apply(null,a)}m.displayName="MDXCreateElement"},7465:(e,t,a)=>{a.r(t),a.d(t,{assets:()=>s,contentTitle:()=>o,default:()=>u,frontMatter:()=>r,metadata:()=>l,toc:()=>c});var i=a(7462),n=(a(7294),a(3905));const r={authors:"Hunter",tags:["AuroraPrime","Create","GenAI","Sharon Chen","DPharm"]},o="Sharon Chen Unveils Groundbreaking AI Solutions for Clinical Trials at DPharm",l={permalink:"/blog/2024/09/24/Sharon Chen Unveils Groundbreaking AI Solutions for Clinical Trials at DPharm",source:"@site/blog/2024-09-24-Sharon Chen Unveils Groundbreaking AI Solutions for Clinical Trials at DPharm.md",title:"Sharon Chen Unveils Groundbreaking AI Solutions for Clinical Trials at DPharm",description:"AI-powered automation promises to accelerate clinical trials, reduce costs, and improve accuracy, making life-saving treatments available to patients faster.",date:"2024-09-24T00:00:00.000Z",formattedDate:"September 24, 2024",tags:[{label:"AuroraPrime",permalink:"/blog/tags/aurora-prime"},{label:"Create",permalink:"/blog/tags/create"},{label:"GenAI",permalink:"/blog/tags/gen-ai"},{label:"Sharon Chen",permalink:"/blog/tags/sharon-chen"},{label:"DPharm",permalink:"/blog/tags/d-pharm"}],readingTime:4.885,hasTruncateMarker:!1,authors:[{name:"Hunter Shen",title:"generative AI evangelist",imageURL:"https://video.myaurora.cn/adhoc/huntershen.jpeg",key:"Hunter"}],frontMatter:{authors:"Hunter",tags:["AuroraPrime","Create","GenAI","Sharon Chen","DPharm"]},nextItem:{title:"Choosing the Right Tool for Your Job",permalink:"/blog/2024/09/23/Choosing the Right Tool for the Job"}},s={authorsImageUrls:[void 0]},c=[{value:"Transforming Clinical Trials with AI",id:"transforming-clinical-trials-with-ai",level:3},{value:"A New Era of Efficiency and Accuracy",id:"a-new-era-of-efficiency-and-accuracy",level:3},{value:"Seamless Integration for Medical Writers",id:"seamless-integration-for-medical-writers",level:3},{value:"Eliminating Hallucinations: The AI Challenge",id:"eliminating-hallucinations-the-ai-challenge",level:3},{value:"AI\u2019s Role in the Future of Pharma",id:"ais-role-in-the-future-of-pharma",level:3}],h={toc:c};function u(e){let{components:t,...r}=e;return(0,n.kt)("wrapper",(0,i.Z)({},h,r,{components:t,mdxType:"MDXLayout"}),(0,n.kt)("p",null,(0,n.kt)("img",{src:a(8204).Z,width:"800",height:"492"})),(0,n.kt)("p",null,(0,n.kt)("em",{parentName:"p"},"AI-powered automation promises to accelerate clinical trials, reduce costs, and improve accuracy, making life-saving treatments available to patients faster.")),(0,n.kt)("p",null,"At the prestigious DPharm event, Sharon Chen, CEO and co-founder of AlphaLife Sciences, took the stage to deliver a keynote that left the audience both inspired and intrigued. In a speech filled with vision and technical insight, Chen outlined how her company is revolutionizing clinical trials through AI-powered solutions that promise to drastically reduce costs, enhance accuracy, and speed up the delivery of life-saving medicines. "),(0,n.kt)("p",null,"Chen\u2019s message resonated deeply with an audience of pharma industry leaders and tech innovators who share a common challenge: the ever-rising costs and complexities of clinical trials. \u201cClinical trials are becoming more expensive and time-consuming, and the urgency to bring treatments to patients faster has never been greater,\u201d Chen said. Her solution? Generative AI\u2014an emerging technology that is already proving its transformative potential across various industries."),(0,n.kt)("h3",{id:"transforming-clinical-trials-with-ai"},"Transforming Clinical Trials with AI"),(0,n.kt)("p",null,"AlphaLife Sciences, headquartered in Singapore, is a four-year-old startup making waves globally for its innovative approach to clinical trial management. The company collaborates with leading pharmaceutical and CRO (Contract Research Organization) companies to bring generative AI solutions into clinical trial workflows. With prestigious partnerships including Google for Startups, Microsoft for Startups, Nvidia's Inception Program, and Johnson & Johnson\u2019s JLab, AlphaLife is rapidly gaining traction as a leader in clinical trial innovation."),(0,n.kt)("p",null,"Chen explained that her company\u2019s flagship platform, ",(0,n.kt)("strong",{parentName:"p"},"AuroraPrime"),", leverages generative AI to address some of the most critical pain points in clinical trials\u2014specifically, medical writing and documentation. The platform is designed to automate the creation of complex reports like Clinical Study Reports (CSRs), cutting down the time and labor traditionally required for this critical task."),(0,n.kt)("p",null,"\u201cIn the medical writing process, teams face the challenge of consolidating information from various sources\u2014internal data, public information, and external collaborations,\u201d Chen remarked. \u201cThis is a time-consuming process prone to human error, but it\u2019s one that can be dramatically improved with AI.\u201d"),(0,n.kt)("h3",{id:"a-new-era-of-efficiency-and-accuracy"},"A New Era of Efficiency and Accuracy"),(0,n.kt)("p",null,"During her keynote, Chen highlighted three pivotal areas where generative AI can drive change: first draft automation, efficient template configuration, and full lifecycle integration of documents. According to her, these innovations will not only accelerate the creation of clinical trial documents but also ensure higher quality and consistency."),(0,n.kt)("p",null,"\u201cEveryone knows the power of tools like ChatGPT for generating content quickly,\u201d Chen noted. \u201cBut in regulated scientific fields like clinical trials, quality is paramount. The content must be consistent, precise, and accurate\u2014AI cannot afford to make mistakes here.\u201d"),(0,n.kt)("p",null,"AlphaLife's solution? A rigorous AI framework that teaches models how to produce scientifically accurate, regulation-compliant content for medical writers. The AI is trained to summarize complex protocols, analyze statistical data, and generate tables and figures with a level of consistency that is critical in clinical trials. Importantly, medical writers remain at the heart of the process, using AI as a tool to assist but not replace their expertise."),(0,n.kt)("h3",{id:"seamless-integration-for-medical-writers"},"Seamless Integration for Medical Writers"),(0,n.kt)("p",null,"A standout feature of the AuroraPrime platform is its seamless integration with the tools medical writers already use, such as Microsoft Word and Real-Time Data (RTD) systems. \u201cWe wanted to make sure the transition to AI-powered solutions would be as smooth as possible for medical writers,\u201d Chen said. \u201cOur platform integrates directly into their existing workflow, which means they can continue working in the environments they are most comfortable with.\u201d"),(0,n.kt)("p",null,"Chen further explained how the platform makes it easy for medical writers to configure templates without needing to write any code. Once a template is set up, it can be reused across multiple documents, further streamlining the process and reducing manual effort. The platform even enables content reuse across different studies, saving significant time in the creation of new reports."),(0,n.kt)("p",null,"\u201cWe\u2019ve designed AuroraPrime to handle the full lifecycle of clinical trial documents,\u201d Chen explained. \u201cFrom protocol creation to final submissions, AI is driving efficiencies at every step, reducing errors and accelerating the process.\u201d"),(0,n.kt)("h3",{id:"eliminating-hallucinations-the-ai-challenge"},"Eliminating Hallucinations: The AI Challenge"),(0,n.kt)("p",null,"A major concern within the AI community is the issue of \u201challucination,\u201d where AI models generate false or misleading content. Chen acknowledged this challenge, especially in the highly regulated pharmaceutical space. \u201cHallucination is a real issue when using general-purpose models,\u201d she said. \u201cBut our solution is built differently. By training the AI with golden datasets, generated from historical clinical trial documents, we\u2019ve minimized this risk.\u201d"),(0,n.kt)("p",null,"Chen\u2019s team has developed an advanced quality control mechanism, ensuring that the AI\u2019s outputs meet the strict scientific and regulatory standards required in clinical trial documentation. The framework allows medical writers to fine-tune AI outputs, providing prompts and examples that guide the model in real time. This flexibility ensures that every document produced meets the highest standards of accuracy and consistency."),(0,n.kt)("h3",{id:"ais-role-in-the-future-of-pharma"},"AI\u2019s Role in the Future of Pharma"),(0,n.kt)("p",null,"In her closing remarks, Chen was optimistic about the future of AI in healthcare. \u201cAI is not just about cutting costs and saving time\u2014although those are clear benefits,\u201d she said. \u201cIt\u2019s about improving the quality and reliability of the documents that are so critical in clinical trials. It\u2019s about helping medical writers do their jobs better, and ultimately, it\u2019s about bringing life-saving treatments to patients faster.\u201d"),(0,n.kt)("p",null,"Chen's keynote made it clear that AlphaLife Sciences is at the forefront of a critical transformation in the pharmaceutical industry. With generative AI, the tedious and error-prone process of clinical trial documentation is becoming faster, more efficient, and more reliable. As AlphaLife continues to innovate and push the boundaries of what AI can do, the future of clinical trials looks increasingly bright."),(0,n.kt)("p",null,"As the keynote wrapped up, attendees were invited to visit AlphaLife\u2019s booth for a hands-on demonstration of the AuroraPrime platform. There was palpable excitement in the room, as industry professionals and innovators alike could see the potential of AI-driven solutions to address one of the most pressing challenges in modern drug development."))}u.isMDXComponent=!0},8204:(e,t,a)=>{a.d(t,{Z:()=>i});const i=a.p+"assets/images/image_20240923230973-889bfad6d3c663f1e59c88c6518d1574.png"}}]);